Advertisement

Early Findings of Computed Tomography and Angiography in Acute Stroke and Thrombolytic Therapy

  • R. von Kummer
Conference paper

Abstract

Before thrombolytic treatment in acute stroke, a computed tomographic (CT) scan is necessary to exclude brain hemorrhage and other causes of focal neurological deficit imitating cerebral ischemia. Angiographic demonstration of arterial occlusion is a precondition for local intraarterial infusion of thrombolytics. At present, several major clinical trials testing the effect of intravenous thrombolytic treatment in acute stroke are conducted without the information of initial angiography so as to gain time for early treatment [1–3]. So far, there are only a few reports available concerning the significance of CT scan and angiography for thrombolytic treatment [4–7]. We studied the question whether positive signs of cerebral ischemia in CT scan such as parenchymal hypodensity and focal brain swelling, together with the angiographically proved site of arterial occlusion and state of collateral blood supply, have predictive value for arterial recanalization and clinical outcome in hemispheric stroke. The significance of angiography in basilar artery occlusion is reported elsewhere in these proceedings (See Chapter, “Thrombolytic Therapy of Basilar Artery Occlusion: Preconditions for Recanalization and Good Clinical Outcome,” in this volume). Data of subgroups of patients reported here have been published previously [8–10].

Keywords

Middle Cerebral Artery Occlusion Acute Ischemic Stroke Thrombolytic Therapy Arterial Occlusion Thrombolytic Treatment 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Kaste M, Fieschi C, Hacke W, Lesaffre E, Verstraete M, Fröhlich J (1993) The European cooperative acute stroke study (ECASS). In: del Zoppo GJ, Mori E, Hacke W (eds) Thrombolytic therapy in acute ischemic stroke II. Springer, Berlin Heidelberg, pp 66–71CrossRefGoogle Scholar
  2. 2.
    Brott T (1993) Symptom-based trials of intravenous rt-PA in acute stroke. In: del Zoppo GJ, Mori E, Hacke W (eds) Thrombolytic therapy in acute ischemic stroke II. Springer, Berlin Heidelberg, pp 39–44CrossRefGoogle Scholar
  3. 3.
    Donnan GA, Davis SM, Chambers BR, Gates PC, Hankey GJ, Stewart-Wynne EG, Rosen D, Tuck RR, McNeil JJ (1993) Australian streptokinase trial (ASK). In: del Zoppo GJ, Mori E, Hacke W (eds) Thrombolytic therapy in acute ischemic stroke II. Springer, Berlin Heidelberg, pp 80–85CrossRefGoogle Scholar
  4. 4.
    Wolpert SM, Brückmann H, Greenlee R, Wechsler L, Pessin MS, del Zoppo GJ, and the rt-PA Acute Stroke Study Group (1993) Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. AJNR 14: 3–13Google Scholar
  5. 5.
    Mori E, Tabuchi M, Yoshida T, Yamadori A (1988) Intracarotid urokinase with thromboembolic occlusion of the middle cerebral artery. Stroke 19: 802–812PubMedCrossRefGoogle Scholar
  6. 6.
    Hacke W (1993) Thrombolysis: stroke subtype and embolus type. In: del Zoppo GJ, Mori E, Hacke W (eds) Thrombolytic therapy in acute ischemic stroke II. Springer, Berlin Heidelberg, pp 153–159CrossRefGoogle Scholar
  7. 7.
    Forsting M, Krieger D, von Kummer R, Hacke W, Sartor K (1993) In: del Zoppo GJ, Mori E, Hacke W (eds) Thrombolytic therapy in acute ischemic stroke II. Springer, Berlin Heidelberg, pp 160–167CrossRefGoogle Scholar
  8. 8.
    von Kummer R, Hacke W (1992) Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery stroke. Stroke 23: 646–652CrossRefGoogle Scholar
  9. 9.
    von Kummer R, Forsting M (1993) Effects of recanalization and collateral blood supply on infarct extent and brain edema after middle cerebral artery occlusion. Cerebrovasc Dis 3: 252–255CrossRefGoogle Scholar
  10. 10.
    von Kummer R, Meyding-Lamadé U, Forsting M, Rosin L, Rieke K, Hacke W, Sartor K (1994) Sensitivity and prognostic value of early computed tomography in middle cerebral artery trunk occlusion. AJNR 15: 9–15Google Scholar
  11. 11.
    Scandinavian Stroke Study Group (1985) Multicenter trial of hemodilution in ischemic stroke. Background and study protocol. Stroke 16: 885–890CrossRefGoogle Scholar
  12. 12.
    van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJA, van Gijn J (1988) Interobserver agreement for the assessment of handicap in stroke patients. Stroke 19: 604–607PubMedCrossRefGoogle Scholar
  13. 13.
    del Zoppo GJ, Poeck K, Pessin MS, Wolpert SM, Furlan AJ, Ferbert A, Alberts MJ, Zivin J, Wechsler L, Busse O, Greenlee R, Brass L, Mohr JP, Feldmann E, Hacke W, Kase CS, Biller J, Gress D, Otis SM (1992) Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 32: 78–86PubMedCrossRefGoogle Scholar
  14. 14.
    Ringelstein EB, Biniek R, Weiller C, Ammeling B, Nolte PN, Thron A (1992) Type and extent of hemispheric brain infarctions and clinical outcome in early and delayed middle cerebral artery recanalization. Neurology 42: 289–298PubMedGoogle Scholar
  15. 15.
    Bozzao L, Fantozzi LM, Bastianello S, Bozzao A, Fieschi C (1989) Early collateral blood supply and late parenchymal brain damage in patients with middle cerebral artery occlusion. Stroke 20: 735–740PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Tokyo 1995

Authors and Affiliations

  • R. von Kummer
    • 1
  1. 1.Department of NeuroradiologyUniversity of Heidelberg Medical SchoolHeidelbergGermany

Personalised recommendations